1.53
price up icon6.25%   0.09
after-market Handel nachbörslich: 1.53
loading

Innate Pharma Adr Aktie (IPHA) Neueste Nachrichten

pulisher
Nov 14, 2024

Earnings call: Innate Pharma Q3 2024 results highlight oncology pipeline - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Earnings call: Innate Pharma focuses on advancing cancer therapies - Investing.com

Nov 14, 2024
pulisher
Sep 13, 2024

Earnings call: Innate Pharma reports progress in drug development - Investing.com India

Sep 13, 2024
pulisher
Sep 12, 2024

Earnings call: Innate Pharma reports progress in oncology pipeline - Investing.com

Sep 12, 2024
pulisher
Jul 06, 2024

Innate Pharma S.A. ADR (IPHA-Q) QuotePress Release - The Globe and Mail

Jul 06, 2024
pulisher
Jul 04, 2024

Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update - The Globe and Mail

Jul 04, 2024
pulisher
Jul 04, 2024

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update - The Globe and Mail

Jul 04, 2024
pulisher
Jun 23, 2024

Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag - Yahoo Movies UK

Jun 23, 2024
pulisher
Jun 10, 2024

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Jun 10, 2024
pulisher
Jun 10, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Jun 10, 2024
pulisher
May 24, 2024

Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting - Investing.com India

May 24, 2024
pulisher
May 14, 2024

Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress - Investing.com

May 14, 2024
pulisher
Apr 10, 2024

All You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy - Yahoo Finance

Apr 10, 2024
pulisher
Mar 31, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 31, 2024
pulisher
Dec 19, 2022

Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis - Zacks Investment Research

Dec 19, 2022
pulisher
Apr 29, 2022

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities News

Apr 29, 2022
pulisher
Dec 11, 2020

The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine ... - Yahoo Finance

Dec 11, 2020
pulisher
Aug 11, 2020

The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/ - Benzinga

Aug 11, 2020
pulisher
Mar 17, 2020

The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga

Mar 17, 2020
pulisher
Jan 03, 2020

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance

Jan 03, 2020
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):